Recent Updates
Recently added Catalysts
ORIC Positive Sentiment Score: 75/100

ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference

Key Takeaway: ORIC Pharmaceuticals, Inc. has announced it will present at the Leerink Partners Global Biopharma Conference on March 13, 2024. The presentation will cover a company overview and their focus on developing therapies that combat mechanisms of therapeutic resistance in oncology. Investors can access the live webcast through the company's website, with a replay available for 90 days post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • ORIC Pharmaceuticals is set to present at a notable biopharma conference.
  • The presentation aims to provide insights into their innovative oncology treatments.
  • The company is focused on addressing therapeutic resistance, which is a critical area in oncology.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will present a company overview at the Leerink Partners Global Biopharma Conference on Wednesday, March 13, 2024, at 8:00 a.m. ET.
A live webcast of the presentation will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc.
Dominic Piscitelli, Chief Financial Officer

Frequently Asked Questions

When will ORIC Pharmaceuticals present at the Leerink Partners Conference?

ORIC Pharmaceuticals will present on March 13, 2024, at 8:00 a.m. ET.

How can I watch the ORIC Pharmaceuticals presentation?

The presentation will be streamed live on the investor section of their website.

Is there a replay available for the presentation?

Yes, a replay of the webcast will be accessible for 90 days after the event.

Who is the CFO of ORIC Pharmaceuticals?

Dominic Piscitelli is the Chief Financial Officer of ORIC Pharmaceuticals.

Last updated: Mar 6, 2024